NasdaqCM - Nasdaq Real Time Price USD

Sanara MedTech Inc. (SMTI)

Compare

29.43

+0.74

+(2.58%)

At close: April 17 at 4:00:00 PM EDT

28.86

-0.57

(-1.94%)

Pre-Market: 6:08:01 AM EDT

Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

FORT WORTH, TX, April 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today that management will present at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub, which is being held at the

GlobeNewswire 10 days ago

SMTI
+2.58%
Sanara MedTech Full Year 2024 Earnings: EPS Misses Expectations

Sanara MedTech ( NASDAQ:SMTI ) Full Year 2024 Results Key Financial Results Revenue: US$86.7m (up 33% from FY 2023...

Simply Wall St. 25 days ago

SMTI
+2.58%
Sanara MedTech Inc (SMTI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ...

Sanara MedTech Inc (SMTI) reports a 33% increase in net revenue, driven by robust sales of soft tissue products, while navigating increased expenses and strategic expansions.

GuruFocus.com 26 days ago

SMTI
+2.58%
Sanara MedTech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited)

Q4 Net Revenue Increased 49% Year-Over-Year; 2024 Net Revenue Increased 33% Year-Over-Year FORT WORTH, TX, March 25, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today reported its financial results for the fourth quarter

GlobeNewswire 26 days ago

SMTI
+2.58%
Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

FORT WORTH, TX, March 11, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today announced it will report its fourth quarter and full year 2024 financial results on Tuesday, March 25, 2025 before the U.S. financial markets open. The Company wi

GlobeNewswire last month

SMTI
+2.58%
Investors in Sanara MedTech (NASDAQ:SMTI) have seen strong returns of 215% over the past five years

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Simply Wall St. last month

SMTI
+2.58%
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.

SHANNON, Ireland, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Irish medical device company Biomimetic Innovations Limited, an affiliate of PBC Biomed, today announced the execution of an exclusive license and distribution agreement with Sanara MedTech Inc (“Sanara”) (Nasdaq:SMTI). In tandem, Sanara agreed to make a minority investment in cash for equity in BMI. Sanara is a medical technology company based in Fort Worth, Texas, focused on developing and commercializing transformative technologies to improv

GlobeNewswire 2 months ago

SMTI
+2.58%
Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd

OsStic® and related technologies represent differentiated solutions that address an estimated 100,000+ procedures in the U.S. annually(1); arrangement leverages Sanara’s existing call points and commercial infrastructure, and complements Sanara’s existing surgical portfolio FORT WORTH, TX, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on deve

GlobeNewswire 2 months ago

SMTI
+2.58%
Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments

Elizabeth Taylor Appointed Chief Financial Officer; Michael McNeil Appointed Chief Accounting Officer and Chief Administrative Officer FORT WORTH, TX, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chro

GlobeNewswire 2 months ago

SMTI
+2.58%
Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024

Fourth Quarter Net Revenue Expected to Increase 45% to 48% Year-Over-Year; Full Year Net Revenue Expected to Increase 32% to 33% Year-Over-Year FORT WORTH, TX, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgi

GlobeNewswire 2 months ago

SMTI
+2.58%
Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th

FORT WORTH, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today that Ron Nixon, the Company’s Chairman and Chief Executive Officer, will present at the

GlobeNewswire 4 months ago

SMTI
+2.58%
Sanara MedTech Inc. (NASDAQ:SMTI) Just Reported Earnings, And Analysts Cut Their Target Price

Sanara MedTech Inc. ( NASDAQ:SMTI ) just released its latest quarterly results and things are looking bullish. Results...

Simply Wall St. 5 months ago

SMTI
+2.58%
Sanara MedTech Third Quarter 2024 Earnings: Beats Expectations

Sanara MedTech ( NASDAQ:SMTI ) Third Quarter 2024 Results Key Financial Results Revenue: US$21.7m (up 35% from 3Q...

Simply Wall St. 5 months ago

SMTI
+2.58%
Sanara MedTech Inc (SMTI) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

Sanara MedTech Inc (SMTI) achieves its 12th consecutive record revenue quarter, while navigating increased expenses and strategic expansions.

GuruFocus.com 5 months ago

SMTI
+2.58%
Sanara MedTech Inc. Reports Third Quarter 2024 Results

FORT WORTH, TX, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today reported its strategic, operational and financial results for the quarter ended September 30, 202

GlobeNewswire 5 months ago

SMTI
+2.58%
Sanara MedTech Inc. (NASDAQ:SMTI) insiders have significant skin in the game with 30% ownership

Key Insights Sanara MedTech's significant insider ownership suggests inherent interests in company's expansion A total...

Simply Wall St. 5 months ago

SMTI
+2.58%
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates

FORT WORTH, TX, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today announced details for the release of its results for the quarter ended September 30, 2024. Sanara

GlobeNewswire 5 months ago

SMTI
+2.58%
Sanara MedTech Inc. Announces Changes to Its Board of Directors

FORT WORTH, TX, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. -- Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets announced today changes to its Board of Directors (“Board”). After a long tenure of service with the predecessor company and Sanara, Mr. James “Jim” Stuckert has resigned from hi

GlobeNewswire 6 months ago

SMTI
+2.58%
Sanara MedTech's (NASDAQ:SMTI) investors will be pleased with their solid 259% return over the last five years

Sanara MedTech Inc. ( NASDAQ:SMTI ) shareholders have seen the share price descend 12% over the month. But in stark...

Simply Wall St. 6 months ago

SMTI
+2.58%
Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC

FORT WORTH, TX, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets, and InfuSystem, Inc. (“InfuSystem”), the operational subsidiary of Sanara’s joint venture partner InfuSystem Holdings, Inc., announced today the execution of an

GlobeNewswire 7 months ago

SMTI
+2.58%
INFU

Performance Overview

Return	SMTI	S&P 500 (^GSPC)
YTD	-11.36%	-10.18%
1-Year	-6.87%	+5.19%
3-Year	+2.15%	+20.26%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Sanara MedTech Inc. (SMTI)

Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Sanara MedTech Full Year 2024 Earnings: EPS Misses Expectations

Sanara MedTech Inc (SMTI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ...

Sanara MedTech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited)

Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

Investors in Sanara MedTech (NASDAQ:SMTI) have seen strong returns of 215% over the past five years

Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.

Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd

Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments

Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024

Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th

Sanara MedTech Inc. (NASDAQ:SMTI) Just Reported Earnings, And Analysts Cut Their Target Price

Sanara MedTech Third Quarter 2024 Earnings: Beats Expectations

Sanara MedTech Inc (SMTI) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

Sanara MedTech Inc. Reports Third Quarter 2024 Results

Sanara MedTech Inc. (NASDAQ:SMTI) insiders have significant skin in the game with 30% ownership

Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates

Sanara MedTech Inc. Announces Changes to Its Board of Directors

Sanara MedTech's (NASDAQ:SMTI) investors will be pleased with their solid 259% return over the last five years

Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC

Performance Overview